Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 8 | 2024 | 1692 | 0.340 |
Why?
|
| Dendritic Cells | 8 | 2010 | 435 | 0.320 |
Why?
|
| Herpesvirus 4, Human | 4 | 2024 | 644 | 0.260 |
Why?
|
| Antigen Presentation | 6 | 2011 | 112 | 0.250 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2024 | 294 | 0.230 |
Why?
|
| Immunotherapy, Adoptive | 5 | 2019 | 950 | 0.230 |
Why?
|
| Lymphoma | 2 | 2024 | 331 | 0.200 |
Why?
|
| Cancer Vaccines | 4 | 2010 | 190 | 0.200 |
Why?
|
| Killer Cells, Natural | 3 | 2016 | 342 | 0.190 |
Why?
|
| Antigens, Viral | 1 | 2024 | 392 | 0.190 |
Why?
|
| Antigens, CD19 | 2 | 2019 | 190 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 495 | 0.160 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2011 | 510 | 0.150 |
Why?
|
| Transduction, Genetic | 3 | 2016 | 279 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 148 | 0.130 |
Why?
|
| Adenoviridae | 4 | 2019 | 580 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2016 | 276 | 0.130 |
Why?
|
| K562 Cells | 2 | 2016 | 97 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2003 | 70 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 847 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 690 | 0.090 |
Why?
|
| Lymphocyte Activation | 4 | 2016 | 627 | 0.090 |
Why?
|
| Th1 Cells | 2 | 2010 | 156 | 0.090 |
Why?
|
| Oncolytic Viruses | 2 | 2009 | 75 | 0.090 |
Why?
|
| Receptors, Antigen | 1 | 2011 | 33 | 0.090 |
Why?
|
| Mice | 13 | 2024 | 18208 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2001 | 71 | 0.080 |
Why?
|
| Immunotherapy | 3 | 2011 | 755 | 0.080 |
Why?
|
| Flow Cytometry | 5 | 2012 | 770 | 0.070 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 53 | 0.070 |
Why?
|
| Viral Vaccines | 1 | 2010 | 316 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 110 | 0.070 |
Why?
|
| Genetic Vectors | 4 | 2019 | 900 | 0.070 |
Why?
|
| Animals | 13 | 2024 | 33891 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2006 | 22 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 230 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 461 | 0.060 |
Why?
|
| AIDS Vaccines | 1 | 2006 | 31 | 0.060 |
Why?
|
| Neoplasms | 3 | 2009 | 2956 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 587 | 0.060 |
Why?
|
| Virus Latency | 1 | 2024 | 63 | 0.050 |
Why?
|
| Blood Component Removal | 2 | 2016 | 35 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 389 | 0.050 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2003 | 6 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2023 | 46 | 0.050 |
Why?
|
| Cell Line | 4 | 2010 | 2569 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2003 | 112 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 126 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 175 | 0.050 |
Why?
|
| Telomerase | 1 | 2003 | 155 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 784 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 479 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2006 | 508 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2010 | 661 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 6 | 2010 | 4695 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 1307 | 0.040 |
Why?
|
| Cytokines | 2 | 2023 | 1339 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2024 | 308 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 2341 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2000 | 59 | 0.040 |
Why?
|
| Vaccination | 1 | 2006 | 1034 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2010 | 113 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2011 | 3700 | 0.040 |
Why?
|
| Retroviridae | 1 | 2019 | 182 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 691 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2001 | 401 | 0.030 |
Why?
|
| Melanoma, Experimental | 2 | 2010 | 36 | 0.030 |
Why?
|
| Antigens | 2 | 2010 | 104 | 0.030 |
Why?
|
| Interleukin-12 | 2 | 2009 | 124 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 673 | 0.030 |
Why?
|
| Feeder Cells | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 36 | 0.030 |
Why?
|
| Humans | 10 | 2024 | 130776 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2474 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2003 | 493 | 0.030 |
Why?
|
| HIV Infections | 1 | 2006 | 2015 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 975 | 0.020 |
Why?
|
| Cell Separation | 2 | 2003 | 220 | 0.020 |
Why?
|
| 4-1BB Ligand | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 713 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2012 | 77 | 0.020 |
Why?
|
| Epitopes | 2 | 2003 | 321 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 110 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2012 | 104 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2009 | 1919 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 232 | 0.020 |
Why?
|
| Flagellin | 1 | 2010 | 20 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 2001 | 28 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 300 | 0.020 |
Why?
|
| Peptides | 2 | 2003 | 710 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 578 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 839 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2010 | 118 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 1623 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 962 | 0.020 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2009 | 3 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2009 | 12 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2010 | 319 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 246 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2905 | 0.020 |
Why?
|
| Alleles | 2 | 2003 | 1671 | 0.020 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2000 | 4670 | 0.020 |
Why?
|
| Oncolytic Virotherapy | 1 | 2009 | 90 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 271 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 978 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 230 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1012 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2008 | 144 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 539 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2006 | 13 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2006 | 10 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 25 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1593 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2006 | 3831 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2006 | 227 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10021 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 235 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 491 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 2003 | 14 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2003 | 64 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 47 | 0.010 |
Why?
|
| Insecta | 1 | 2003 | 50 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 2003 | 97 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 15011 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 194 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 320 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2003 | 225 | 0.010 |
Why?
|
| Nucleocapsid | 1 | 2000 | 6 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 2001 | 54 | 0.010 |
Why?
|
| Hepatitis B Core Antigens | 1 | 2000 | 14 | 0.010 |
Why?
|
| Hepatitis B e Antigens | 1 | 2000 | 14 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20832 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 66 | 0.010 |
Why?
|
| Thymoma | 1 | 2001 | 21 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 596 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2001 | 158 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1311 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2000 | 357 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 2000 | 137 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2397 | 0.010 |
Why?
|
| Child | 1 | 2019 | 26214 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3488 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2126 | 0.010 |
Why?
|
| Software | 1 | 2003 | 736 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2558 | 0.010 |
Why?
|
| Male | 3 | 2011 | 64680 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1950 | 0.010 |
Why?
|
| Female | 3 | 2009 | 70630 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2000 | 902 | 0.010 |
Why?
|